IL1B and COVID-19–associated multisystem inflammatory syndrome in children: Given the familiarity with IL-1 blockade in KD and the demonstration that IL-1b played a major role in the inflammation in MIS-C, anakinra was used in the treatment of MIS-C patients early in the pandemic [11].